FTC approves Eckerd sale
This article was originally published in The Rose Sheet
Executive Summary
FTC has completed its review of J.C. Penney's sale of its Eckerd drug store operations to The Jean Coutu Group and CVS and has granted an early termination of the waiting period under Hart-Scott-Rodino, J.C. Penney announces June 1. Transaction is still expected to close by the end of the year, firm adds. J.C. Penney announced the sale in early April (1"The Rose Sheet" April 12, 2004, In Brief)...
You may also be interested in...
Eckerd sale
J.C. Penney will sell its Eckerd drugstore chain to Brooks Pharmacy owner Jean Coutu and drugstore retailer CVS for $4.53 bil., company announces April 5. Jean Coutu will acquire 1,539 Eckerd stores and support facilities located in thirteen Northeast and mid-Atlantic states, as well as the Eckerd home office for $2.38 bil. Stores under Jean Coutu will retain the Eckerd name. CVS will acquire 1,260 Eckerd stores and support facilities located in southern states including Florida, Texas and Arizona, in addition to Eckerd's pharmacy benefits management and mail order business, for $2.15 bil. The firm plans to reopen the Eckerd stores under the CVS name. Transactions are expected to close by the end of the second quarter, subject to regulatory approvals...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.